1. Home
  2. YSG vs WVE Comparison

YSG vs WVE Comparison

Compare YSG & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YSG
  • WVE
  • Stock Information
  • Founded
  • YSG 2016
  • WVE 2012
  • Country
  • YSG China
  • WVE Singapore
  • Employees
  • YSG N/A
  • WVE N/A
  • Industry
  • YSG Package Goods/Cosmetics
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • YSG Consumer Discretionary
  • WVE Health Care
  • Exchange
  • YSG Nasdaq
  • WVE Nasdaq
  • Market Cap
  • YSG 889.0M
  • WVE 915.6M
  • IPO Year
  • YSG 2020
  • WVE 2015
  • Fundamental
  • Price
  • YSG $10.32
  • WVE $10.15
  • Analyst Decision
  • YSG
  • WVE Strong Buy
  • Analyst Count
  • YSG 0
  • WVE 16
  • Target Price
  • YSG N/A
  • WVE $20.00
  • AVG Volume (30 Days)
  • YSG 540.3K
  • WVE 1.6M
  • Earning Date
  • YSG 08-21-2025
  • WVE 07-30-2025
  • Dividend Yield
  • YSG N/A
  • WVE N/A
  • EPS Growth
  • YSG N/A
  • WVE N/A
  • EPS
  • YSG N/A
  • WVE N/A
  • Revenue
  • YSG $522,879,337.00
  • WVE $93,946,000.00
  • Revenue This Year
  • YSG $17.93
  • WVE N/A
  • Revenue Next Year
  • YSG $12.79
  • WVE $4.55
  • P/E Ratio
  • YSG N/A
  • WVE N/A
  • Revenue Growth
  • YSG 11.53
  • WVE N/A
  • 52 Week Low
  • YSG $3.01
  • WVE $5.04
  • 52 Week High
  • YSG $11.57
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • YSG 63.61
  • WVE 72.29
  • Support Level
  • YSG $8.90
  • WVE $9.26
  • Resistance Level
  • YSG $9.99
  • WVE $9.93
  • Average True Range (ATR)
  • YSG 0.66
  • WVE 0.50
  • MACD
  • YSG 0.09
  • WVE 0.11
  • Stochastic Oscillator
  • YSG 96.20
  • WVE 84.68

About YSG Yatsen Holding Limited

Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: